ArticleCureus2025
Prevalence of Diabetic Peripheral Neuropathy and Its Associated Risk Factors Among Patients With Type 2 Diabetes Mellitus in the Chengalpattu District of Tamil Nadu.
Article in Cureus, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
1 citing paper in PubMed.
- Next-generation microneedle platforms for site-specific management of diabetic neuropathy.Diabetology & metabolic syndrome · 2025Review
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
5 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Background Diabetic peripheral neuropathy (DPN) is a common diabetic consequence that damages nerves and results in pain, numbness, and sensory loss. It has no known treatment, impairs mobility, and increases the risk of foot ulcers; therefore, early therapy is necessary. The objective of this study was to determine the factors associated with DPN in individuals with type 2 diabetes mellitus (T2DM). Methodology A cross-sectional study was conducted from July 2024 to December 2024 among 310 people who attended the diabetic outpatient department (OPD) of a tertiary care hospital in Chengalpattu district. The Neuropathy Disability Score (NDS), Neuropathy Symptom Score (NSS), and Morisky Medication Adherence Scale-8 (MMAS-8) were used, and data were collected and analyzed using IBM SPSS Statistics for Windows, V. 25.0 (IBM Corp., Armonk, NY, USA). Analytical tests such as the chi-squared test and odds ratio were used to find an association between DPN and its associated variables such as age, sex, glycated hemoglobin (HbA1c), and the duration of illness following which the enter method of logistic regression analysis was performed. Results Out of 310 participants, the prevalence of DPN was found to be present in 88 (28.4%). DPN was found to be significantly associated with education (adjusted odds ratio (AOR): 0.33, 95%CI: 0.15-0.74), marital status (AOR: 2.88, 95%CI: 1.52-5.47), comorbidities (AOR: 2.07, 95%CI: 1.05-4.08), and type of medication (AOR: 2.59, 95%CI: 1.29-5.21). Conclusion About 88 (28.4%) of people had DPN; those who were hypertensive and used insulin to control their DM were at a greater risk. Routine screening and control of blood sugar and blood pressure are essential for patients with DM.
Indexed as
Identifiers
What Socratic holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.